An interventional study of True TECAR Therapy and Sham TECAR in Knee Osteoarthritis, sponsored by Middle East University. Completed at 1 site in Egypt. Open to male participants aged 65 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Middle East University · Not applicable, Interventional, and Treatment
Evaluate the effect of TECAR therapy combined with traditional physiotherapy on pain, balance, and quality of life in elderly men with knee osteoarthritis .
Eighty elderly men diagnosed with knee osteoarthritis will be recruited from physical therapy and orthopedic outpatient clinics. Following a baseline screening, patients will be randomly assigned into two parallel groups:
The Study Group: Will include 40 men participating in true TECAR therapy plus a standardized traditional physiotherapy program for 8 weeks.
The Control Group: Will include 40 men participating in sham TECAR therapy plus the same traditional physiotherapy program for 8 weeks.
3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
This study's enrollment of 80 is above the median of 68 across 2,714 interventional studies indexed under Osteoarthritis, Knee.
Browse Osteoarthritis, Knee studies →Middle East University is the lead sponsor of 19 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Platelets
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
40 elderly men with knee osteoarthritis who will receive TECAR therapy combined with a traditional physiotherapy program for 8 weeks
Device: True TECAR Therapy · Other: Traditional Physiotherapy
Will include 40 men participating in sham TECAR therapy plus the same traditional physiotherapy program for 8 weeks
Device: Sham TECAR · Other: Traditional Physiotherapy
20 minutes per session (10 mins capacitive mode, 10 mins resistive mode), 3 sessions per week for 8 weeks will be applied around the affected knee joint. Thermal delivery will be adjusted to a comfortable, non-painful warm sensation
The device will be applied using identical electrode placement, application time, and interface screen indicators, but with the power output disabled so that no current or deep thermal energy is transferred to the tissues.
Standardized knee osteoarthritis rehabilitation including progressive quad/hamstring strengthening, hip abductor strengthening, range of motion exercises, and flexibility training
Balance
Berg Balance Scale will be used to assess balance. The Berg Balance Scale is a 14-item objective clinical assessment designed to measure static and dynamic balance capabilities, with total scores ranging from a minimum of 0 to a maximum of 56, where higher scores indicate a better outcome (greater functional stability, increased independence, and lower fall risk).
Time frame: Baseline and after 8 weeks
Pain Intensity
Visual Analog Scale will be used to assess pain intensity. Visual Analog Scale score ranges from 0 to 10, with higher scores indicate more severe pain.
Time frame: Baseline and after 8 weeks
Health-Related Quality of Life
Short Form-12 Health Survey will be used to assess quality of life. The Short Form-12 Health Survey is a twelve-item self-reported questionnaire designed to assess generic health-related quality of life across Physical Component Summary and Mental Component Summary domains, with standardized scores ranging from a minimum of zero to a maximum of one hundred, where higher scores indicate a better outcome (better physical health, mental health, and overall functional performance).
Time frame: Baseline and after 8 weeks
Quadriceps Isokinetic Strength
An isokinetic dynamometer assesses concentric quadriceps muscle strength and power bilaterally. Participants perform maximal voluntary knee extensions and flexions at specific angular velocities of 60 and 180 degrees.
Time frame: Baseline and after 8 weeks
Isokinetic Knee Flexion / Extension Range of Motion
Will be assessed using an isokinetic dynamometer which simultaneously tracks joint range of motion (in degrees) via built-in optical encoders.
Time frame: Baseline and after 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2026 to primary completion in Oct 2026, 3 months.
Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 3 months is below that.
Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Middle East University